KOSDAQAerospace & Defense088290

Ewon Comfortech

₩1,989▼ 3.91%2026-11-18 close
Market Cap
₩15.9B
Turnover
₩25,110,218
Volume
10K
Shares out.
8M
PER
40.6×
PBR
2.0×
EPS
₩53
Dividend Yield
0.00%

PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q4–2026Q3) · Dividend yield is based on ₩0 per share · Prices as of the 2026-11-18 close

01

Report overview

Captive truck-seat supply; capital recovery is the open test

Ewon Comfortech's quarterly results still swing with its main automaker's production schedule, and its thin equity base is the next item to watch.

  1. 1

    Q1 2026 revenue fell 40.3% year on year to KRW 8.55 billion, and the company swung to an operating loss of KRW 859 million. Management attributed the drop to a temporary production cut tied to line works at Hyundai Motor's Jeonju plant.

  2. 2

    Q2 2026 revenue rose to KRW 15.5 billion with operating profit of KRW 1.34 billion, a swing back to profit. Q3 2026 operating profit then fell to KRW 259 million, down 80.6% from the prior quarter.

  3. 3

    The net loss attributable to controlling shareholders ran for four consecutive years from 2022 to 2025, narrowing to KRW 4.1 billion in 2025 from KRW 21 billion in 2024.

  4. 4

    Total equity was KRW 9.53 billion at the end of 2025, below a paid-in capital base of roughly KRW 19.9 billion, and the debt-to-equity ratio rose from 60.3% in 2023 to 148.7% in 2025.

  5. 5

    In May 2026 the company said it aims to resolve early the delisting-watch trigger tied to capital impairment.

02

Business structure

Ewon Comfortech was founded in 1994 and listed on KOSDAQ in 2009 as an auto parts maker. Its sector label is aerospace and defense, but the business confirmed in filings and press coverage is commercial-vehicle seating.

The company is a certified supplier of seats for all truck models and bus driver seats to Hyundai Motor, KIA and Hyundai Mobis. Hyundai Motor and KIA accounted for 75.3% of revenue in the first nine months of 2025, up 3.1 percentage points from a year earlier, so dependence on a few customers is high.

Its own brand NEXSIS, described as high-margin, booked KRW 2.59 billion of sales in that period, down 7% year on year. Overseas sales were KRW 3.56 billion in the same period, up 3.1%. The company exports air suspension units to Japan and China and air suspension seats to Europe.

It is widening into special-purpose vehicle seats for construction and agricultural machinery to move beyond OEM-only work. A November 2025 press report put its share of the domestic commercial-vehicle seat market above 80%. Competition is shaped by long-term supply relationships and design-response capability with automakers.

03

Earnings trend

Quarterly revenue · Operating profit
RevenueOperating profit
Annual revenue · Operating profit
RevenueOperating profit
Quarterly results · Last 5 quarters
QuarterRevenueOperating profitOp. margin
2025Q3₩15.6B₩1.1B6.8%
2025Q4———
2026Q1₩8.5B-₩900M−10.1%
2026Q2₩15.5B₩1.3B8.6%
2026Q3₩11.8B₩300M2.2%
Annual results
YearRevenueOperating profitNet income (parent)Op. marginROEDebt-to-equity
2022₩47.8B₩1.7B-₩9.6B3.6%−19.5%97.6%
2023₩47.1B₩900M-₩2.4B1.9%−4.8%60.3%
2024₩52.5B₩2.5B-₩21B4.7%−102.4%120.8%
2025₩56.6B₩1.6B-₩4.1B2.8%−43.0%148.7%

Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-11-14

04

Earnings analysis

Annual revenue went from KRW 47.8 billion in 2022 to KRW 47.1 billion in 2023, down 1.4%, then rose to KRW 52.5 billion in 2024 (up 11.4%) and KRW 56.6 billion in 2025 (up 7.8%). Revenue has grown for two consecutive years, and 2025 was the largest year of 2022 to 2025.

Operating profit was KRW 1.7 billion in 2022, the smallest year at KRW 880 million in 2023 (down 48.4%), then KRW 2.47 billion in 2024 (up 180.9%), the largest year of the four. It fell 36.3% to KRW 1.57 billion in 2025. Operating margin was 3.6% in 2022, 1.9% in 2023, 4.7% in 2024 and 2.8% in 2025.

Revenue peaked in 2025, but the margin was lower than in 2024, so top-line growth did not translate into higher profit.

The net loss attributable to controlling shareholders was KRW 9.64 billion in 2022, KRW 2.4 billion in 2023, KRW 21 billion in 2024 and KRW 4.1 billion in 2025, and the net loss including non-controlling interests followed the same pattern.

In its 2025 year-end settlement the company said it had reflected a substantial part of the value decline on its earlier Liminatus Pharma investment, as reported in May 2026.

Operating cash flow went from KRW 8.46 billion in 2022 to -KRW 56.55 million in 2023 and -KRW 961 million in 2024, then turned to KRW 2.74 billion in 2025.

By quarter, Q3 2025 showed revenue of KRW 15.6 billion, operating profit of KRW 1.06 billion and net income attributable to controlling shareholders of KRW 597 million. There is no quarterly figure for Q4 2025 in the periodic filings, leaving a gap in the sequence.

Q1 2026 revenue dropped to KRW 8.55 billion, with an operating loss of KRW 859 million and a net loss attributable to controlling shareholders of KRW 1.54 billion.

Q2 2026 revenue recovered to KRW 15.5 billion (up 81.5% from the prior quarter), with operating profit of KRW 1.34 billion and net income attributable to controlling shareholders of KRW 1.06 billion. Q3 2026 revenue of KRW 11.8 billion fell 24.3% from the prior quarter and 24.5% from a year earlier.

Operating profit of KRW 259 million was down 75.7% year on year, while net income attributable to controlling shareholders of KRW 843 million rose 41.3%, so operating profit and that net income moved in opposite directions.

Net income attributable to controlling shareholders for the latest four quarters (Q4 2025 to Q3 2026) totaled KRW 499 million.

05

Industry analysis

Commercial-vehicle seats are tied to automakers' new-model line schedules, so earnings respond quickly to temporary disruptions such as line construction. Domestic auto demand in 2026 has a recovery in the domestic market, but demand is described as still constrained.

Exports are seen as having a brighter outlook on easing tariff uncertainty and rising exports of eco-friendly vehicles. Commercial-vehicle demand is linked to logistics and construction activity, according to press analysis.

Seats are essential parts with steady replacement and maintenance demand, another analysis notes. The company said it is developing an air suspension seat function to prepare for automakers' expanding global sourcing.

Press coverage puts its domestic commercial-vehicle seat share above 80%, which is cited as a strong domestic supply position. Overseas sales were KRW 3.56 billion in the first nine months of 2025, only a part of total revenue.

Hanwha Aerospace and Korea Aerospace Industries share the aerospace and defense sector label, but their business structures and demand cycles differ, so they are hard to use as direct benchmarks.

The key signal for the cycle is whether the Q1 2026 production disruption was temporary and whether output returned to normal levels from Q2 onward.

06

Outlook

In its Q1 2026 results announcement in May 2026, the company said shipments of deferred orders would resume from Q2 and that high-margin special-purpose vehicle seats would expand. It said overtime and weekend shifts had been running since April 2026.

In line with that explanation, Q2 2026 revenue rose 81.5% from the prior quarter to KRW 15.5 billion and turned to operating profit of KRW 1.34 billion. However, Q3 2026 revenue fell 24.3% from the prior quarter to KRW 11.8 billion, showing that the deferred-order effect has not been even from quarter to quarter.

The company aims to resolve early the delisting-watch trigger linked to capital impairment through core operating profit. Liminatus shares of about 4.37 million acquired as of December 31, 2025 were booked as an asset, and the company said this means no delisting-watch issue arises.

The company said it is pursuing market entry in Southeast Asia. At the March 2026 annual general meeting, a share consolidation and an amendment to the articles of incorporation were approved.

The next checkpoints are whether Hyundai Motor's production schedule normalizes through the end of 2026 and how total equity changes.

07

Valuation

PER
40.6×
PBR
2.0×
ROE
5.1%
EPS
₩53
BPS
₩1,092
Dividend per share
₩0

The price-to-book ratio is above 1x, so the stock trades above book value per share. Total equity at the end of 2025 was KRW 9.53 billion, below a paid-in capital base of roughly KRW 19.9 billion, so asset-based readings should be viewed alongside the capital recovery.

Earnings-based multiples are sensitive to earnings swings, because net income attributable to controlling shareholders for the latest four quarters totals only KRW 499 million. Net income attributable to controlling shareholders rose in Q3 2026 while operating profit fell, so the composition of earnings matters.

No dividend payments appear in recent filings, so a dividend-based valuation case is weak. The CEO bought 100,000 shares on the open market, raising holdings to 181,375 shares as of December 31, 2025, according to a disclosure.

PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-11-14

08

Bull factors

Long-standing automaker supply ties

Certified supply of all truck-model seats and bus driver seats to Hyundai Motor and KIA is cited as a basis for a durable demand base. Hyundai Motor and KIA reached 75.3% of revenue in the first nine months of 2025, up 3.1 percentage points, which shows the supply relationship is holding. Analysts also note that seats are essential parts with steady replacement demand.

Export growth and higher-value products

Air suspension units are exported to Japan and China, and air suspension seats to Europe. Overseas sales were KRW 3.56 billion in the first nine months of 2025, up 3.1% from a year earlier. Analysts classify air suspension as a higher-value product that also supports profitability. Southeast Asia entry is also being pursued.

Q2 swing to profit and loss recognition

The Q2 operating profit reflects a turnaround from the prior quarter's loss, and whether it continues in later quarters is the next point to check. Net income attributable to controlling shareholders also turned positive at KRW 1.06 billion.

The company said it had reflected a substantial part of the Liminatus investment's value decline in its 2025 settlement, so further losses are limited.

09

Bear factors

Customer concentration and production disruption

Q1 2026 revenue fell 40.3% year on year, with the cause traced to line construction at the main customer's Jeonju plant. With high customer concentration, automaker production schedules flow directly into results.

Q3 2026 revenue fell 24.3% from the prior quarter, showing that normalization has not been steady quarter to quarter.

Thin margins and mixed earnings signals

Operating margin was 3.6% in 2022, 1.9% in 2023, 4.7% in 2024 and 2.8% in 2025, a thin range. Q3 2026 operating profit of KRW 259 million fell 75.7% year on year. Net income attributable to controlling shareholders of KRW 843 million rose in the same quarter, moving opposite to operating profit.

Thin equity and rising leverage

Total equity at the end of 2025 was KRW 9.53 billion and total liabilities KRW 14.2 billion. The debt-to-equity ratio rose from 60.3% in 2023 to 120.8% in 2024 and 148.7% in 2025. Equity below paid-in capital is being cited as a trigger for delisting-watch status.

10

Risk factors

Customer and production schedule

Quarterly revenue moves sharply with automaker production schedules and new-model line works. The Q1 2026 decline came from this same structure. With a high share from a few customers, changes in volume allocation flow straight into results.

Capital impairment and delisting-watch risk

Total equity is below paid-in capital, and capital impairment is being cited. The company plans to resolve it through operating profit, but repeated operating losses could delay that. The effect of booking the Liminatus shares as an asset on the capital structure will be a point to re-check in the next periodic report.

Past investment losses and shareholder structure

The company invested KRW 30 billion in an investment fund in 2020 and later booked about KRW 7 billion of losses, while biotech-related news moved the share price sharply. A former major shareholder's stake has also fallen to 5% or below. The effect of ownership changes on management direction will need to be tracked through disclosures.

11

What to watch next

  1. Fiscal year-end, December 31, 2026

    This is the reference date for checking whether total equity recovers to the level of paid-in capital and whether the capital impairment cited as a delisting-watch trigger is resolved.

  2. End of March 2027 (annual report deadline)

    The 2026 annual report will confirm full-year revenue, operating margin, net income attributable to controlling shareholders and year-end 2026 total equity as disclosed results.

  3. Around May 15, 2027 (Q1 quarterly report deadline)

    This is the point to check whether automaker production disruptions recur in Q1 2027 and whether the profit trend seen since Q2 2026 continues.

12

Overall view

Ewon Comfortech is an auto parts maker whose core business is commercial-vehicle seats. Its sector label is aerospace and defense, but the confirmed business is supply to automakers.

The net loss attributable to controlling shareholders ran for four consecutive years from 2022 to 2025, and the 2025 figure of KRW 4.1 billion was smaller than KRW 21 billion in 2024. Operating profit peaked at KRW 2.47 billion in 2024 and fell to KRW 1.57 billion in 2025, with operating margin at a low 2.8%.

In Q1 2026, production disruption at Hyundai Motor's Jeonju plant cut revenue 40.3% and produced a loss. Q2 2026 returned to profit with revenue of KRW 15.5 billion and operating profit of KRW 1.34 billion, but Q3 2026 operating profit of KRW 259 million fell 75.7% year on year.

Net income attributable to controlling shareholders for the latest four quarters totals KRW 499 million, and total equity at the end of 2025 was KRW 9.53 billion, below paid-in capital.

Strengths include long-standing automaker supply, exports and the Q2 return to profit, while weaknesses include customer concentration, thin equity and low margins. The next checkpoints are the full-year results in the 2026 annual report, year-end 2026 total equity, and production effects in Q1 2027.

13

Sources

  1. Korea Exchange (KRX) — Prices · Market Cap · Volume
  2. FSS electronic disclosure system (DART) — Financial statements · Dividend filings
Show 16 more articles and sources
  1. comp.fnguide.com
  2. comp.wisereport.co.kr
  3. nwww.newsis.com
  4. newspim.com
  5. pinpointnews.co.kr
  6. core.asiae.co.kr
  7. marketin.edaily.co.kr
  8. edaily.co.kr
  9. digitaltoday.co.kr
  10. newspim.com
  11. markets.hankyung.com
  12. edaily.co.kr
  13. jobkorea.co.kr
  14. digitaltoday.co.kr
  15. jobkorea.co.kr
  16. m.news.nate.com

Report written 2026-11-14 · Data as of 2026-11-13

This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.

Other reports in this industry

View industry analysis